Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Development of EBM-fabricated titanium alloy parts for high performance leightweighting

Reference number
Coordinator Chalmers Tekniska Högskola AB - Industri- och materialvetenskap
Funding from Vinnova SEK 3 600 000
Project duration September 2019 - August 2023
Status Completed
Venture The strategic innovation programme SIP LIGHTer

Important results from the project

The project focuses on electron beam melting (EBM) as AM technology for Ti alloy in both aerospace and biomedical applications. The goals of this project are i) to build confidence to use additive manufacturing (AM) for highly loaded components that would benefit significantly from the design in aerospace applications where fatigue loading is critical, and ii) to further develop AM as a main approach for bionic design demonstrated for future medical parts.

Expected long term effects

The microstructure of EBM-produced Ti6Al4V and fractography after fatigue tests were investigated and compared with LPBF-produced parts. The possible reason for the early fracture and the large spread of fatigue life was figured out. In vitro cell cultures showed good inflammatory cell attachment and viability to both implants made of virgin and recycled powders. Improved cell survival for the implants produced by recycled powder correlates with the increased oxide thickness. The knowledge obtained ensures robust EBM manufacturing and high performance of components.

Approach and implementation

For aerospace application, the original plan was followed in general. One change was that we used 4-point bending to evaluate the fatigue property instead of a small punch test. We also did a comparison with LPBF-produced parts which was not covered in the original proposal. For bio-application, the lack of expertise in the machining of implants made it difficult to miniaturize suitable implants for the intended small animal model. In the end, we reverted from in vivo to in vitro where larger samples could be used, to obtain preclinical data on the role of powder recycling.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 16 November 2023

Reference number 2019-02607